That’s So Metal: Dr. Jessica Sheldon Targets Acinetobacter Baumannii
Release Date: 09/28/2025
Inside the Next Chapter of Biomedical Science, with Dr. Linda Chelico
Researchers Under the Scope
As Researchers Under the Scope marks its 100th episode, we hand the microphone to Dr. Linda Chelico, who recently accepted a five-year term as Vice-Dean Research, Biomedical Sciences, at the University of Saskatchewan’s College of Medicine. Originally from Melfort, Saskatchewan, the virologist and biochemist outlines her two main priorities: upgrading research infrastructure and raising the public profile of her colleagues’ work. Since the Covid-19 pandemic, Chelico said biomedical researchers are now expected to team up producing multiple lines of...
info_outline
'Health Really Is Wealth': Dr. Holly Graham
Researchers Under the Scope
Dr. Holly Graham never planned on nursing. She wanted a police badge, then a law degree and a judge’s bench. Instead, she followed her mother’s wish and walked into nursing school as the only student from a reserve in a class of more than 200. The isolation was real. So were the health gaps she saw every shift. In this episode, Graham traces her path from being the only Cree nurse in her graduating class, to becoming a professor of psychiatry, registered doctoral psychologist, and . Her curiosity about widespread health disparities for Indigenous people pushed her back to university,...
info_outline
Inside a Drug Trial for a Rare Childhood Disease: Drs. Sarah Tehseen & Katie Felton
Researchers Under the Scope
Most childhoods don’t involve sitting at the hospital for an infusion of medication, transfusions on weekends, or worrying that classmates will comment on the colour of your skin. For one Saskatoon teen with an ultra-rare blood disease, that’s everyday life. She was diagnosed with a form of anemia so uncommon only a handful of cases have been identified globally. In this episode, & share how they’re working to change her “normal” by opening a phase 3 pharmaceutical trial and fighting for a better quality of life. We hear how Tehseen and Felton each got into...
info_outline
This Is Your Brain After Anesthetic: Dr. Peter Hedlin
Researchers Under the Scope
Peter Hedlin (PhD, MD) recalls being a ‘young, naïve medical student’ when he asked a mentor a question that’s stuck with him for years. “I remember asking how anaesthetics work on the brain,” said Hedlin. “And he said, ‘we actually don’t really know’. And I thought that was crazy.” Today, at the University of Saskatchewan’s College of Medicine. He examines what surgery and sedation do to the human body — in particular, to aging brains. Trained first as a microbiologist who earned his PhD as a vaccine researcher at , Hedlin was always drawn to medicine. He...
info_outline
Not Just Numbers: Vaidehee Lanke Tracks Opiate Use & Perinatal Health
Researchers Under the Scope
In this episode, medical student and researcher shares what large provincial datasets reveal about opioid use disorder, maternal mental health, and pregnancy. Armed with data, she hopes better support —before, during, and after birth—can change outcomes for mothers and babies. Lanke spent her summer working with epidemiologist and the Saskatchewan Population Health and Evaluation Research Unit on a pan-Canadian project tracking opioid use in perinatal populations across five provinces. “The question we set out to answer was: What is the association between...
info_outline
Cross-Linked Clues: Jack Walther on Depression and Alzheimer's
Researchers Under the Scope
As a student, Jack Walther's friends often came to him when they needed a listening ear, or help with relationship struggles. This summer, Walther took his fascination with the brain and mood disorders to , learning to untangle some of the tiny molecular threads that might explain why depression so often shows up alongside dementia. Walther and the research team dug into the physical interactions between serotonin and the beta amyloid peptides that build up in patients with Alzheimer's disease. . He admits going from the classroom to the laboratory felt like a sharp learning curve. "It was...
info_outline
EEEV-ident Passion: Eve Simpson on Doubt, Persistence and Viral Spread
Researchers Under the Scope
Eve Simpson knows from experience scientific research doesn’t always follow a linear path. In the first of three student research episodes, the fourth-year biochemistry, microbiology and immunology student looks back at a summer spent decoding Eastern Equine Encephalitis Virus (EEEV) in ’s lab. Simpson said she loved doing bench research, but felt frustrated in the moments where she hit setbacks and moments of doubt. “I felt like I was letting everyone down,” she said. “But everyone I spoke to said they'd been through that. It's part of being a researcher. That's what drives us to do...
info_outline
That’s So Metal: Dr. Jessica Sheldon Targets Acinetobacter Baumannii
Researchers Under the Scope
Jessica Sheldon (PhD) is on a mission to starve out Acinetobacter baumannii —one of the world’s most virulent hospital-borne pathogens. Notorious for its speedy evolution and multi-drug resistance, the hospital-borne bacteria lingers on dry surfaces and infects critically-ill patients, leading to sepsis, pneumonia and high mortality rates. In this episode, delves into the real-life events that drove her to investigate histamine, and its role in bacterial survival and immune response. In 2022, Sheldon joined the University of Saskatchewan’s College of Medicine as an assistant professor...
info_outline
Fluid Endeavour: Kirk Haan's Medical Balancing Act
Researchers Under the Scope
Kirk Haan graduated from high school, thinking he’d study pharmacy at the University of Saskatchewan, and walk out five years later. After one summer at a pharmacy, Haan realized he was after a more ‘hands-on’ career in medicine. “I’ve kind of worked with my hands my whole life, just between rummaging around on a farm and always kind of building things,” he said. “Now it’s using them to help people in a direct way.” Then, Haan found his passion — inside the laboratory. In 2018, Haan landed a summer position in , studying osmoregulation — the mechanisms that govern...
info_outline
Dr. Sébastien Gauvrit: Fishing for Answers in Vascular Development
Researchers Under the Scope
Sébastien Gauvrit (PhD) was only ten when his family let him have his first tank of guppies. Within weeks, he was hooked. “I actually had to understand genetics directly by mixing these different fish together to get the colour or fin shape I was interested in,” said the vascular biologist and genetic modelling pioneer. From his home in France, to post-doctoral work pioneering new models for vascular disease in Germany, to his current position as an assistant professor of Anatomy, Physiology and Pharmacology at the University of Saskatchewan’s College of Medicine — tropical fish...
info_outlineJessica Sheldon (PhD) is on a mission to starve out Acinetobacter baumannii —one of the world’s most virulent hospital-borne pathogens.
Notorious for its speedy evolution and multi-drug resistance, the hospital-borne bacteria lingers on dry surfaces and infects critically-ill patients, leading to sepsis, pneumonia and high mortality rates.
In this episode, Sheldon delves into the real-life events that drove her to investigate histamine, and its role in bacterial survival and immune response.
In 2022, Sheldon joined the University of Saskatchewan’s College of Medicine as an assistant professor of Biochemistry, Microbiology & Immunology -- something she now laughs about after an ill-fated high school placement in an immunology laboratory.
“Cytokine cascades, pathways, the signaling just got way over my head real fast,” said Sheldon. “I didn’t really know what I was doing.”
Sheldon enrolled at Lakehead University, drawn to the tiny pathogens with outsized roles in movies like Outbreak. She estimates she read the book The Hot Zone 20 times.
Her persistence paid off.
“One of my second year microbiology teachers said, ‘you know, I think you're kind of good at this. Maybe you should try it as a career.’
Sheldon zeroed in on metals and wrote her doctoral dissertation on the role iron plays in the proliferation of bacteria such as Methicillin-resistant staphylococcus aureus (MRSA).
Today, she studies both Morganella morganii and Acinetobacter baumannii — the multi-drug-resistant bacteria singled out twice in the last decade by the World Health Organization as a ‘priority 1-critical pathogen’.
“I’m perpetually fascinated by the idea that something so small can change the course of history,” said Sheldon. “And we’ve seen that recently with COVID.”
Sheldon was already studying the metal uptake and signalling systems that grow and sustain A. baumannii when the bacteria ripped through hospitals during the pandemic, attacking Covid-infected patients on ventilators.
By 2023, Sheldon landed a five-year CIHR grant of $900,000 to study A. Baumannii and the way it turns histidine into histamine. Her goal is to pinpoint the way the pathogen uses histamine to evade its host, as it sends out siderophores to steal iron and other nutrients.
The compound appears to serve as a signalling mechanism for both the host and the invading pathogen, she said.
“We know the bacteria are using histamine in the synthesis of these molecules to get iron, but they're also secreting it into the environment. We're not really sure why,” Sheldon said.
Her laboratory is working to trace and target those pathways, so researchers can identify and potentially develop new treatments — small molecules or antibody inhibitors that could disrupt multi-drug resistant pathogens.
Beyond A. baumannii, histamine may hold the key to how some of the world's most notorious bacteria grow, spread, and evade immune defences, Sheldon said.
“We're running out of drugs, but there's really not a full appreciation for the fact that we're losing the ability to treat bacterial infections,” Sheldon said.
“We need to develop supplementary therapies or alternative therapies.”